After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q3 2018 call → NOWe need to determine if management reports that the most important positive developments of the period happened so late in the reported period or shortly after it ended that the results contain little or none of their effect, with management itself marking the timing. Let's analyze the transcript. The call is for Q3 2018. Key events: TIBSOVO approval and launch in July (which is early in Q3, not late). However, there are other developments: the sNDA submission for newly diagnosed AML planned by end of January 2019 (after quarter end), the acceleration of the Phase 3 AGILE trial, the acquisition of worldwide rights to AG-881 from Celgene in September (which is late in Q3), and the IND submission for AG-636 (submitted, but not yet started trials). Also, the upcoming ASH presentations. The question asks: "On this call, does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented contain little or none of their effect — with management itself marking the timing?" We need to see if management explicitly says that these developments happened late and that the reported results (e.g., financial results) don't reflect them. For example, the TIBSOVO launch started in July, so it's within Q3. The $4.5 million in sales is for the partial quarter. That's not late. The AG-881 rights acquisition in September is late in Q3, but that's a business development event, not a revenue-generating event. The sNDA submission is planned for January 2019, after quarter end, but that's a regulatory submission, not a revenue event. The AGILE trial enrollment completion is expected in 2020, not a current event. Management does not seem to frame any of these as "the results contain little or none of their effect." They discuss the launch progress, but they don't say that the quarter's results miss the impact of late-breaking events. They do mention that the sNDA submission is planned, but that's future. The AG-881 rights acquisition is a strategic move, but they don't say it affects the quarter's financials. The question is about "MOST IMPORTANT POSITIVE DEVELOPMENTS" and whether they happened so late that the results don't reflect them. The most important positive development is the TIBSOVO launch, which started in July, so it's within the quarter.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...